China’s National Medical Products Administration (NMPA) has issued a new regulatory framework clarifying post-approval obligations...
Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA) announced a definitive agreement to acquire Organon & Co....
AstraZeneca plc (NYSE: AZN) announced that China’s National Medical Products Administration (NMPA) has granted approvals...
Insilico Medicine (HKG: 3696), a China-based artificial intelligence (AI) drug discovery platform, announced the selection...
Star Sports Medicine Co., Ltd., a Chinese sports medical device manufacturer, successfully completed its initial...
Huadong Medicine Co., Ltd. (SHE: 000963) announced it has received marketing approval from China’s National...
Sisram Medical Ltd (HKG: 1696), an Israel-based aesthetic medical technology company and subsidiary of Fosun...
China Medical System Holdings Limited (CMS; HKG: 0867) announced that the National Medical Products Administration...
AbbVie Inc. (NYSE: ABBV) disclosed on April 23, 2026, that it has received a Complete...
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) announced that the U.S. Food and Drug Administration (FDA) has...
Thermo Fisher Scientific Inc. (NYSE: TMO) announced first-quarter 2026 financial results with revenue growing 6%...
China’s National Health Commission (NHC) released a draft notification for public consultation on comprehensive revisions...
SciClone Pharmaceuticals Inc (HKG: 6600) announced a strategic partnership agreement with JD Healthcare (HKG: 6618),...
Roche AG (SWX: ROP, OTCMKTS: RHHBY) reported first-quarter 2026 group sales of CHF 14.7 billion...
Transcenta Holdings Ltd (HKG: 6628) has presented pre-clinical data for its proprietary LIV1 antibody-drug conjugate...
Simcere Pharmaceutical Group Limited (HKG: 2096) has withdrawn its New Drug Application (NDA) for rademikibart...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276, HKG: 1276) has released its first quarter 2026...
Sipai Health Technology Co., Ltd. (HKG: 0314), also known as Mebanks, has announced the sale...
Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) has announced the initiation of a single-center,...
AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical...